Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 12/20 | 0.36 |
| ▸ | PPARG | P37231 | 10/20 | 0.36 |
| ▸ | PPARD | Q03181 | 7/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 4/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 4/20 | 0.31 |
| ▸ | MCTS1 | Q9ULC4 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4472882 | 0.96 | PPARA (0.39) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4381997 | 0.96 | PPARA (0.39) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4484621 | 0.96 | PPARA (0.39) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4484618 | 0.96 | PPARA (0.39) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4375529 | 0.91 | PPARG (0.38) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4391944 | 0.91 | PPARG (0.38) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4386898 | 0.89 | PPARA (0.45) | PPARAPPARGPPARD | |
| SCHEMBL4380740 | 0.89 | PPARA (0.45) | PPARAPPARGPPARD | |
| SCHEMBL4382593 | 0.89 | PPARA (0.37) | PPARAPPARGPPARDSLC16A3SLC16A1 | |
| SCHEMBL4388898 | 0.89 | PPARA (0.37) | PPARAPPARGPPARDSLC16A3SLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789402-B1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-1789402-A1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | Sanofi-Aventis Deutschland GmbH (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006018118-A1 | 2 - {-3-`2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-02-23 | — | — | WO | disclosed |